|
186 Products |
| 186 Products |
|
1696 Diseases |  |
94663 News |  |
| «12...10431044104510461047104810491050105110521053...10631064» |
- ||||| dexamethasone / Generic mfg., bendamustine / Generic mfg., pomalidomide / Generic mfg.
Clinical: Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma (clinicaltrials.gov) - Dec 19, 2012
P1/2, N=56, Recruiting, Sponsor: Cristina Gasparetto
- dexamethasone / Generic mfg., lenalidomide / Generic mfg., carfilzomib / Generic mfg.
Clinical: Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma (clinicaltrials.gov) - Dec 18, 2012
P1/2, N=25, Active, not recruiting, Sponsor: University of Michigan Cancer Center
Recruiting --> Active, not recruiting
- Lucentis (ranibizumab) / Roche, Novartis
Trial completion, Combination therapy, Monotherapy: Lucedex: A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD (clinicaltrials.gov) - Dec 17, 2012
P1/2, N=40, Completed, Sponsor: Subhransu K. Ray, M.D., Ph.D.
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enbrel (etanercept) / Pfizer, Amgen
Trial completion: The Use of Etanercept (Enbrel (clinicaltrials.gov) - Dec 17, 2012
P2, N=40, Completed, Sponsor: University of Michigan Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Dec 16, 2012
P1, N=18, Recruiting, Sponsor: OHSU Knight Cancer Institute
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| Veramyst (fluticasone furoate nasal spray) / GSK
Enrollment change: A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis (clinicaltrials.gov) - Dec 13, 2012
P3, N=962, Completed, Sponsor: Sandoz Inc.
Not yet recruiting --> Recruiting N=730 --> 962
- ||||| Nasonex (mometasone furoate nasal spray) / Merck (MSD)
Enrollment change: A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis (clinicaltrials.gov) - Dec 13, 2012
P3, N=1103, Completed, Sponsor: Sandoz Inc.
N=730 --> 962 N=700 --> 1103
- ||||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
New P4 trial: SCO116572: A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects (clinicaltrials.gov) - Dec 13, 2012
P4, N=53, Completed, Sponsor: GlaxoSmithKline
- | Sarclisa (isatuximab-irfc) / Sanofi
New P1 trial, Combination therapy: SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients (clinicaltrials.gov) - Dec 13, 2012
P1, N=39, Active, not recruiting, Sponsor: Sanofi
- |||||| bortezomib / Generic mfg., dexamethasone / Generic mfg., pomalidomide / Generic mfg.
Clinical: OPTIMISMM: Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Dec 13, 2012
P3, N=782, Recruiting, Sponsor: Celgene Corporation
N=700 --> 1103 Not yet recruiting --> Recruiting
- | Decadron (dexamethasone) / Merck (MSD)
New P2 trial, Surgery: Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer (clinicaltrials.gov) - Dec 11, 2012
P2, N=72, Recruiting, Sponsor: OHSU Knight Cancer Institute
- | fludrocortisone / Generic mfg., hydrocortisone / Generic mfg.
Trial completion: Corti-TC: Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury (clinicaltrials.gov) - Dec 11, 2012
P3, N=336, Completed, Sponsor: Nantes University Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial termination: Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis (clinicaltrials.gov) - Dec 10, 2012
P=N/A, N=0, Terminated, Sponsor: Southern California Institute for Research and Education
Recruiting --> Completed Recruiting --> Terminated; research staffs unable to continue.
- || Anoro Ellipta (umeclidinium/vilanterol) / Innoviva, GSK
New P3 trial: Study to compare umeclidinium/vilanterol compared with fluticasone propionate/salmeterol in COPD (EUDRACT) - Dec 10, 2012
P3, N=710, Ongoing, Sponsor: GlaxoSmithKline Research & Development Limited
- || prednisolone / Generic mfg., fluticasone / Generic mfg.
New P3 trial: Management of Recurrent Croup (clinicaltrials.gov) - Dec 10, 2012
P3, N=100, Recruiting, Sponsor: University of Michigan
- || Rituxan (rituximab) / Roche
New P2/3 trial: Rituximab in Systemic Sclerosis (clinicaltrials.gov) - Dec 10, 2012
P2/3, N=90, Recruiting, Sponsor: Assistance Publique - H
- | budesonide/formoterol / Generic mfg.
Trial termination: A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) (clinicaltrials.gov) - Dec 9, 2012
P3, N=113, Terminated, Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting --> Terminated; research staffs unable to continue. Recruiting --> Terminated
- || Triesence (triamcinolone acetonide injectable suspension) / Novartis, Avastin (bevacizumab) / Roche
New P3 trial, Surgery: Prevention of macular edema after cataract surgery Het voorkomen van netvlieszwelling na een staaroperatie (EUDRACT) - Dec 9, 2012
P3, N=1350, Ongoing, Sponsor: University Eye Clinic Maastricht
- dexamethasone / Generic mfg., clarithromycin / Generic mfg., pomalidomide / Generic mfg.
Clinical: Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Dec 6, 2012
P2, N=44, Recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
- ||||| dexamethasone / Generic mfg., melphalan / Generic mfg., pomalidomide / Generic mfg.
Clinical: IFM2010-02: Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14) (clinicaltrials.gov) - Dec 6, 2012
P2, N=55, Recruiting, Sponsor: University Hospital, Lille
- budesonide/formoterol / Generic mfg.
Enrollment closed: Effect of Symbicort on Sleep Quality in Patients With Emphysema (clinicaltrials.gov) - Dec 5, 2012
P3, N=40, Active, not recruiting, Sponsor: Temple University
Recruiting --> Terminated Recruiting --> Active, not recruiting
- Decadron (dexamethasone) / Merck (MSD)
Enrollment closed: Trimodality Management of T1b Esophageal Cancers (clinicaltrials.gov) - Dec 5, 2012
P2b, N=30, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- hydrocortisone / Generic mfg.
Trial completion: Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants (clinicaltrials.gov) - Dec 4, 2012
P2, N=64, Completed, Sponsor: Nationwide Children's Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma
Enrollment change: Examine the Efficacy and Safety of a Single Dose of Intravenous MK-0517 (EUDRACT) - Dec 4, 2012
P3, N=990, Ongoing, Sponsor: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.`Merck Corporation, Inc.
Active, not recruiting --> Completed N=50 --> 990
- | dexamethasone / Generic mfg.
New P4 trial: Santeon-CAP; Dexamethasone in Community-acquired Pneumonia (clinicaltrials.gov) - Dec 4, 2012
P4, N=600, Recruiting, Sponsor: St. Antonius Hospital
- hydrocortisone / Generic mfg.
Trial termination: Glucocorticoid Treatment for Social Phobia (clinicaltrials.gov) - Dec 3, 2012
P2, N=66, Terminated, Sponsor: University Hospital Inselspital, Berne
N=50 --> 990 Active, not recruiting --> Terminated; Recruiting problems
- hydrocortisone / Generic mfg.
Enrollment change: Glucocorticoid Treatment for Social Phobia (clinicaltrials.gov) - Dec 3, 2012
P2, N=66, Terminated, Sponsor: University Hospital Inselspital, Berne
Active, not recruiting --> Terminated; Recruiting problems N=160 --> 66
- | prednisone / Generic mfg., methylprednisolone sodium succinate / Generic mfg.
Clinical: Dose of Corticosteroids in COPD (clinicaltrials.gov) - Dec 3, 2012
P4, N=125, Recruiting, Sponsor: University of Medicine and Dentistry New Jersey
- | Istodax (romidepsin) / Astellas, BMS
New P1/2 trial: An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study) (clinicaltrials.gov) - Dec 3, 2012
P1/2, N=100, Recruiting, Sponsor: Yale University
- | QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
New P4 trial: OLiVIA: Effects of QVAR in Smokers With Asthma (clinicaltrials.gov) - Dec 2, 2012
P4, N=40, Not yet recruiting, Sponsor: University Medical Centre Groningen
- Enrollment open: Analgesic Effect of IV Acetaminophen in Tonsillectomies (clinicaltrials.gov) - Dec 2, 2012
P2, N=240, Recruiting, Sponsor: Nationwide Children's Hospital
N=160 --> 66 Not yet recruiting --> Recruiting
- Avastin (bevacizumab) / Roche
Trial completion: Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion (clinicaltrials.gov) - Dec 2, 2012
P=N/A, N=45, Completed, Sponsor: Yeungnam University College of Medicine
Not yet recruiting --> Recruiting Recruiting --> Completed
- | Korlym (mifepristone) / Corcept Therap
New P2 trial: Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone (clinicaltrials.gov) - Nov 29, 2012
P2, N=136, Recruiting, Sponsor: Department of Veterans Affairs
- hydrocortisone / Generic mfg.
Trial completion: Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest (clinicaltrials.gov) - Nov 29, 2012
P=N/A, N=100, Completed, Sponsor: National Taiwan University Hospital
Recruiting --> Completed Recruiting --> Completed
- dexamethasone / Generic mfg., melphalan / Generic mfg., pomalidomide / Generic mfg.
Clinical: Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis (clinicaltrials.gov) - Nov 29, 2012
P2, N=28, Recruiting, Sponsor: IRCCS Policlinico S. Matteo
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Ninlaro (ixazomib) / Takeda
Enrollment closed, Combination therapy: Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma (clinicaltrials.gov) - Nov 28, 2012
P1/2, N=64, Active, not recruiting, Sponsor: Millennium Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| dexamethasone / Generic mfg., cisplatin / Generic mfg., fosaprepitant / Generic mfg.
New P2 trial: Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors (clinicaltrials.gov) - Nov 27, 2012
P2, N=64, Recruiting, Sponsor: Hoosier Oncology Group
- ||| mapracorat (BOL-303242-X) / Bayer
New P1 trial: Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days (clinicaltrials.gov) - Nov 27, 2012
P1, N=61, Completed, Sponsor: Bausch & Lomb Incorporated
- |||||||||| bortezomib / Generic mfg., dexamethasone / Generic mfg., pomalidomide / Generic mfg.
Clinical: OPTIMISMM: Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Nov 26, 2012
P3, N=782, Recruiting, Sponsor: Celgene Corporation
- melphalan / Generic mfg., lenalidomide / Generic mfg.
Enrollment closed: Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis (clinicaltrials.gov) - Nov 26, 2012
P2, N=35, Active, not recruiting, Sponsor: Boston Medical Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||||| Nasonex (mometasone furoate nasal spray) / Merck (MSD)
Trial completion: A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR) (clinicaltrials.gov) - Nov 25, 2012
P3, N=1220, Completed, Sponsor: Perrigo Company
Recruiting --> Active, not recruiting Recruiting --> Completed
- | dexamethasone injection / Generic mfg.
New P4 trial: Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections (clinicaltrials.gov) - Nov 25, 2012
P4, N=108, Recruiting, Sponsor: Weill Medical College of Cornell University
- || Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
New P3 trial: Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) (clinicaltrials.gov) - Nov 25, 2012
P3, N=240, Recruiting, Sponsor: Shandong University
- || dexamethasone injection / Generic mfg.
New P3 trial: rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP (clinicaltrials.gov) - Nov 25, 2012
P3, N=200, Recruiting, Sponsor: Shandong University
- |||||||||| Nasonex (mometasone furoate nasal spray) / Merck (MSD)
New P3 trial, Surgery: Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps (clinicaltrials.gov) - Nov 22, 2012
P3, N=100, Active, not recruiting, Sponsor: Intersect ENT
- | Enrollment closed: Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 (clinicaltrials.gov) - Nov 21, 2012
P3, N=300, Active, not recruiting, Sponsor: Karolinska University Hospital
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: REFLI: Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (clinicaltrials.gov) - Nov 21, 2012
P1, N=48, Completed, Sponsor: Orion Corporation, Orion Pharma
Recruiting --> Active, not recruiting Recruiting --> Completed
- | lenalidomide / Generic mfg.
New P4 trial: Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma (clinicaltrials.gov) - Nov 20, 2012
P4, N=114, Recruiting, Sponsor: Columbia University
- | thioguanine / Generic mfg.
Enrollment change: Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission (clinicaltrials.gov) - Nov 20, 2012
P3, N=1929, Completed, Sponsor: Eastern Cooperative Oncology Group
Recruiting --> Completed N=590 --> 1929
- | dexamethasone injection / Generic mfg.
New P4 trial: DEXA-ARDS: Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Nov 20, 2012
P4, N=314, Not yet recruiting, Sponsor: Dr. Negrin University Hospital